Project Updates
Sandoz
![](/pharma/pharma_sep23/project_updates/1259556/Featured_Image_Sandoz_Biosimilar_Technical_Development_Center_Slovenia.1440_0_1.jpg)
Location: Ljubljana, Slovenia
Project type: Biopharmaceutical development centre
Estimated completion: 2026
Lek Pharmaceuticals, a pharmaceutical company based in Slovenia and a part of Sandoz, will build a state-of-the-art biosimilar technical development centre in Ljubljana, Slovenia, to support the growth of its biosimilar plans.
SCG Cell Therapy
![](/pharma/pharma_sep23/project_updates/1259557/Featured_Image_SCG_Cell_Therapys.1440_0_1.jpg)
Location: Singapore
Project type: Cell therapy manufacturing facility
Opened: July 2023
SCG Cell Therapy opened a new first-of-its-kind cell therapy good-manufacturing-practice certified-(GMP) facility and R&D centre with the support of the Singapore Economic Development Board at its headquarters in Singapore.
Aphena Pharma
![](/pharma/pharma_sep23/project_updates/1259555/Featured_Image_Sandoz_Biosimilar_Technical_Development.1440_0_1.jpg)
Location: Cookeville, Tennessee, US
Project type: Solid dose division expansion
Estimated Investment: $20m
Aphena Pharma Solutions expanded its solid dose division in Cookeville with a $20m expansion and renovation, adding capacity for US FDA-compliant pharmaceutical packaging of solid dose and biologic products.